{"symbol": "BGNE", "companyName": "BeiGene Ltd.", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "http://www.beigene.com", "description": "BeiGene Ltd is a biopharmaceutical company engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. Its product includes BGB-3111, BGB-A317 and BGB-290 and one immuno-oncology agent.", "CEO": "John V. Oyler", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}